statistiche ricercatore

Continente	#
AS - Asia	737
EU - Europa	449
NA - Nord America	448
SA - Sud America	78
AF - Africa	11
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.726

Nazione	#
US - Stati Uniti d'America	422
IT - Italia	198
SG - Singapore	166
CN - Cina	165
HK - Hong Kong	128
VN - Vietnam	127
BR - Brasile	61
DE - Germania	48
NL - Olanda	39
FR - Francia	38
BD - Bangladesh	37
IN - India	34
RU - Federazione Russa	31
GB - Regno Unito	26
FI - Finlandia	25
KR - Corea	20
TR - Turchia	14
MX - Messico	11
JP - Giappone	10
SE - Svezia	10
CA - Canada	9
CO - Colombia	6
GR - Grecia	6
ID - Indonesia	6
IE - Irlanda	6
TW - Taiwan	6
AR - Argentina	5
ES - Italia	4
IQ - Iraq	4
SA - Arabia Saudita	4
AT - Austria	3
CI - Costa d'Avorio	3
ET - Etiopia	3
IL - Israele	3
PH - Filippine	3
UA - Ucraina	3
AU - Australia	2
JO - Giordania	2
KG - Kirghizistan	2
PA - Panama	2
PE - Perù	2
PL - Polonia	2
SK - Slovacchia (Repubblica Slovacca)	2
ZA - Sudafrica	2
AM - Armenia	1
BE - Belgio	1
BG - Bulgaria	1
BY - Bielorussia	1
CL - Cile	1
EC - Ecuador	1
EE - Estonia	1
ER - Eritrea	1
GT - Guatemala	1
HN - Honduras	1
IR - Iran	1
JM - Giamaica	1
LT - Lituania	1
LU - Lussemburgo	1
MA - Marocco	1
MO - Macao, regione amministrativa speciale della Cina	1
MY - Malesia	1
NI - Nicaragua	1
NO - Norvegia	1
PK - Pakistan	1
RO - Romania	1
SC - Seychelles	1
UY - Uruguay	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.726

Nome	#
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review	260
Will the autofluorescence take over inadvertent parathyroidectomy?Results from a multicentre cohort study	216
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm	204
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.	179
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting	168
Changing the paradigm: lobectomy for sporadic medullary thyroid cancer	145
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants	123
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex	116
Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer	112
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism	108
Clinical relevance of the thyroid differentiation score (TDS) in benign and malignant thyroid tumors	82
Impatto della dose iniziale sul trattamento con lenvatinib nel carcinoma tiroideo differenziato avanzato	66
Physical activity and systemic treatment outcomes in advanced thyroid cancer.	10
VALIDATION OF THE 2025 ATA RISK STRATIFICATION SYSTEM IN A COHORT OF PATIENTS WITH PAPILLARY THYROID CARCINOMA	1
Totale	1.790

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	10	0	0	0	0	0	0	0	0	0	0	1	9
2021/2022	49	14	4	2	3	3	4	3	0	10	2	1	3
2022/2023	56	5	3	1	3	5	3	0	4	2	3	21	6
2023/2024	116	10	8	0	11	36	8	8	5	2	2	16	10
2024/2025	380	4	13	3	12	36	18	21	34	23	75	45	96
2025/2026	1.164	88	114	133	74	68	77	263	35	82	98	132	0
Totale													1.790

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca